Rahi Tinni Basu

ORCID: 0009-0000-8585-5793 · 1 paper in corpus
2026
·doi:10.1016/j.xfre.2026.07.005

Dopamine D2 receptor (DRD2) agonists represent a promising targeted, nonhormonal therapeutic strategy for endometriosis. These agents selectively downregulate vascular endothelial growth factor-A signaling, thereby inhibiting the aberrant a…